Monocyte dipeptidyl peptidase 4 activity is associated with urinary albumin excretion in type 2 diabetes

Hideyuki Okuma1, Takahiro Tsutsumi2, Kyoichiro Tsuchiya2

  • 1Department of Diabetes and Endocrinology, Nerima Hikarigaoka Hospital, Tokyo, Japan.

Abstract

Insights

Monocyte dipeptidyl peptidase 4 (DPP4) activity correlates with urinary albumin excretion in type 2 diabetes mellitus (T2DM) patients. This suggests monocytes link DPP4 to diabetic kidney disease (DKD) pathogenesis.

Area of Science:

  • Nephrology
  • Immunology
  • Endocrinology

Background:

  • Diabetic kidney disease (DKD) pathogenesis may involve pro-inflammatory genes in monocytes and dipeptidyl peptidase 4 (DPP4).
  • The specific association between monocyte DPP4 and renal parameters in DKD remains unclear.

Purpose of the Study:

  • To investigate the relationship between monocyte DPP4 expression and activity with renal parameters in patients with type 2 diabetes mellitus (T2DM).

Main Methods:

  • A cross-sectional study compared 64 T2DM patients and 50 healthy controls.
  • Monocytes were isolated, cultured, and stimulated (LPS). DPP4 and pro-inflammatory gene expression, and DPP4 activity were measured.
  • Renal parameters included urinary albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR).

Main Results:

  • Elevated DPP4 gene expression and activity were observed in unstimulated monocytes of T2DM patients compared to controls.
  • In T2DM patients, LPS-stimulated monocyte DPP4 expression correlated positively with UACR and pro-inflammatory gene expression, but not eGFR.
  • Monocyte DPP4 activity (stimulated and unstimulated) positively correlated with UACR and pro-inflammatory gene expression, independent of eGFR.

Conclusions:

  • Monocyte DPP4 activity is linked to urinary albumin excretion in T2DM patients.
  • Monocytes may act as a cellular bridge connecting DPP4 and DKD development.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...